Skip to main content

Pregabalin

NDC 31722-615 · Camber Pharmaceuticals, Inc.

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength200 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

31722-615-05 — 500 CAPSULE in 1 BOTTLE (31722-615-05)

31722-615-31 — 10 BLISTER PACK in 1 CARTON (31722-615-31) / 10 CAPSULE in 1 BLISTER PACK

31722-615-60 — 60 CAPSULE in 1 BOTTLE (31722-615-60)

31722-615-90 — 90 CAPSULE in 1 BOTTLE (31722-615-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

29300-442 — Pregabalin, 29300-443 — Pregabalin, 29300-444 — Pregabalin, 29300-445 — Pregabalin, 29300-446 — Pregabalin, 31722-610 — Pregabalin, 31722-611 — Pregabalin, 31722-612 — Pregabalin, 31722-613 — Pregabalin, 31722-614 — Pregabalin, 31722-616 — Pregabalin, 31722-617 — Pregabalin, 33342-165 — Pregablin, 33342-166 — Pregablin, 33342-167 — Pregablin, 33342-168 — Pregablin, 33342-169 — Pregablin, 33342-170 — Pregablin, 33342-171 — Pregablin, 33342-172 — Pregablin, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels